Crinetics Pharmaceuticals (CRNX) Amortizatization of Intangibles (2019 - 2026)

Crinetics Pharmaceuticals' Amortizatization of Intangibles history runs 8 years deep, the most recent figure standing at $2.2 million for Q1 2026.

• In Q1 2026, Amortizatization of Intangibles fell 49.27% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $858000.0 (down 75.97% YoY), while the FY2025 annual figure was $3.0 million, down 0.92% from the prior year.
• Amortizatization of Intangibles was $2.2 million for Q1 2026 at Crinetics Pharmaceuticals, up from $654000.0 in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $4.7 million in Q2 2025 to a low of -$6.7 million in Q3 2025.
• Historically, Amortizatization of Intangibles has averaged $853705.9 across 5 years, with a median of $759000.0 in 2024.
• The sharpest annual moves came in 2023 and 2024: Amortizatization of Intangibles soared 921.08% in 2023, then tumbled 499.04% in 2024.
• A 5-year view of Amortizatization of Intangibles shows it stood at $351000.0 in 2022, then jumped by 921.08% to $3.6 million in 2023, then sank by 78.82% to $759000.0 in 2024, then dropped by 13.83% to $654000.0 in 2025, then soared by 239.45% to $2.2 million in 2026.
• The last three Amortizatization of Intangibles figures came in at $2.2 million (Q1 2026), $654000.0 (Q4 2025), and -$6.7 million (Q3 2025), per Business Quant data.